Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research · Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mary Horowitz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:53 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04934670 · A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)Xenikos · terminated · Steroid-Refractory Acute Graft Versus Host Disease · study director
- Ph3NCT03959241 · TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)Medical College of Wisconsin · completed · Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia · study director
- Ph2NCT03263559 · Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)Medical College of Wisconsin · completed · Sickle Cell Disease · study director
- Ph2NCT02918292 · Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)Medical College of Wisconsin · completed · Severe Aplastic Anemia · study director
- Ph2NCT02806947 · A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)Medical College of Wisconsin · completed · Acute GVHD · study director
- Ph2NCT02728102 · Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)National Heart, Lung, and Blood Institute (NHLBI) · completed · Multiple Myeloma · study director
- Ph2NCT02440464 · Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)National Heart, Lung, and Blood Institute (NHLBI) · completed · Multiple Myeloma · study director
- Ph3NCT02345850 · Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)National Heart, Lung, and Blood Institute (NHLBI) · completed · Acute Leukemia, Myelodysplasia · study director
- Ph3NCT02322320 · Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)National Heart, Lung, and Blood Institute (NHLBI) · completed · Multiple Myeloma · study director
- Ph2NCT02208037 · Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)National Heart, Lung, and Blood Institute (NHLBI) · completed · Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia · study director
- N/ANCT02081248 · Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)Medical College of Wisconsin · completed · Improve the Informed Consent Process · study director
- Ph2NCT02016781 · Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)Medical College of Wisconsin · completed · MDS · study director
- Ph2NCT01998633 · Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)Medical College of Wisconsin · completed · Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease · study director
- N/ANCT01879072 · Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)Medical College of Wisconsin · completed · Allogeneic Hematopoietic Stem Cell Transplantation · study director
- Ph3NCT01597778 · Double Cord Versus Haploidentical (BMT CTN 1101)Medical College of Wisconsin · completed · Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma · study director
- Ph2NCT01410344 · Allogeneic Transplant in HIV Patients (BMT CTN 0903)Medical College of Wisconsin · completed · Leukemia, Lymphoma, HIV · study director
- Ph3NCT01339910 · Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)Medical College of Wisconsin · terminated · Leukemia, Myelocytic, Acute · study director
- N/ANCT01278927 · Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)Medical College of Wisconsin · completed · Physiological Stress · study director
- Ph2NCT01141712 · Autologous Transplant in HIV Patients (BMT CTN 0803)Medical College of Wisconsin · completed · Lymphoma, HIV · study director
- Ph3NCT01109004 · Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)National Heart, Lung, and Blood Institute (NHLBI) · completed · Multiple Myeloma · study director
- Ph2/Ph3NCT01106833 · Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)Medical College of Wisconsin · completed · Chronic GVHD · study director
- Ph3NCT01002742 · Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)Medical College of Wisconsin · completed · Graft-versus-Host Disease, Immune System Disorders · study director
- Ph2NCT00912223 · Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)Medical College of Wisconsin · completed · Lymphoma, Non-Hodgkin · study director
- Ph2NCT00864227 · Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)Medical College of Wisconsin · completed · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma · study director
- Ph2NCT00849147 · Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)Medical College of Wisconsin · completed · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma · study director
- Ph2NCT00745420 · Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)Medical College of Wisconsin · completed · Sickle Cell Disease · study director
- Ph3NCT00421174 · Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)National Heart, Lung, and Blood Institute (NHLBI) · completed · Pneumonia, Idiopathic Pneumonia Syndrome · study director
- Ph3NCT00412360 · Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)Medical College of Wisconsin · completed · Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia · study director
- Ph3NCT00406393 · Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)Medical College of Wisconsin · completed · Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic · study director
- Ph3NCT00329030 · Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)National Heart, Lung, and Blood Institute (NHLBI) · completed · Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin · study director
- Ph1/Ph2NCT00326417 · Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)Medical College of Wisconsin · completed · Anemia, Aplastic · study director
- Ph2NCT00224874 · Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)National Heart, Lung, and Blood Institute (NHLBI) · completed · Graft vs Host Disease, Immune System Disorders · study director
- Ph2/Ph3NCT00096460 · Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)Medical College of Wisconsin · terminated · Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma · study director
- Ph3NCT00075803 · Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)Medical College of Wisconsin · completed · Lymphoma, Infection, Leukemia · study director
- Ph3NCT00075829 · Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)National Heart, Lung, and Blood Institute (NHLBI) · completed · Multiple Myeloma · study director
- Ph3NCT00075816 · Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)Medical College of Wisconsin · completed · Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani, Brent R Logan, Adam M. Mendizabal · fiscal years 2017 to 2026Named on NCT04934670
- Blood & Marrow Transplant Clinical Trials Network Data Coordinating CenterU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Mary Maresca Horowitz · fiscal years 2011 to 2016
- A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy ResearchU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · fiscal years 1998 to 2026
- BMT Clinical Research Network Data Coordinating CenterU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Mary Maresca Horowitz · fiscal years 2001 to 2010Named on NCT02728102, NCT02440464, NCT02345850, NCT02322320, NCT02208037, NCT01410344, NCT01339910, NCT01278927, NCT01141712, NCT01109004, NCT01106833, NCT01002742, NCT00912223, NCT00864227, NCT00849147, NCT00745420, NCT00421174, NCT00412360, NCT00406393, NCT00329030, NCT00326417, NCT00224874, NCT00096460, NCT00075803, NCT00075816
- AIDS Malignancy Clinical Trials Consortium (AMC)U01CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RONALD T. MITSUYASU · fiscal years 2006 to 2014Named on NCT01141712
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.